Within the immune system, interleukin-15 (IL-15) plays a relevant role by boosting the number of cytotoxic T cells and NK cells, the major drivers of anticancer immune response. Researchers from Sotio ...

The company’s lead candidate, BMB-101, is a 5-HT2C receptor superagonist designed to address disorders like refractory epilepsy and certain neuropsychiatric conditions. The selective targeting of this ...